News – Page 578 – Endpoints News

Broad Institute lands major victory in CRISPR patent fight over UC Berkeley, Nobel winners

4 years ago

A new biotech out of Dana-Farber wants to join the long non-coding RNA party, with help from Bob Langer

4 years ago

Deserted by Sanofi, Lexicon discloses last-minute hiccup in its solo fight to get sotagliflozin approved

4 years ago

'We are ready to go': FDA OKs J&J and Legend's BCMA CAR-T, setting stage for showdown with Bristol Myers

4 years ago

Expanded Intellia CRISPR data set up showdown with Pfizer, Ionis and Alnylam in not-so-rare disease

4 years ago

GlaxoSmithKline consumer business Haleon lays out game plan after July spinout

4 years ago

Sanofi, Regeneron build their case for yet another approval for immunology star Dupixent

4 years ago

Viatris agrees to pay $264M to settle EpiPen class action case

4 years ago

As Eli Lilly steams ahead with a closely-watched BTK drug, its rivals at Merck are taking a $275M write-down on delay

4 years ago

Pharmas rally to protect employees in Ukraine, along with support and donations to Russia-invaded country

4 years ago

Pfizer and Alvotech look to interchangeability to stand out in a crowded Humira biosimilar field

4 years ago

J&J grows investment fund for entrepreneurs, sets 2022 focus on healthcare worker gaps and racial inequities

4 years ago

Emergent's troubled Baltimore site gets $100M upgrade

4 years ago

Safety concerns cause GSK to stop highly anticipated vaccine trial in surprise setback

4 years ago

Appili lands DOD money for bioterrorism vaccine; Goldfinch touts new PhII data

4 years ago

Another burned-out SPAC biotech raises the white flag as CEO departs, strategic review begins

4 years ago

Hold the phone, biopharma: FDA-imposed clinical holds are on the rise

4 years ago

After being ushered onto the inside lane at FDA, regulators hand Amryt a CRL for rare disease drug

4 years ago

Blueprint partners up with a degrader-focused 'vant' as part of pipeline-boosting campaign

4 years ago

Developers of a key mRNA delivery tech, seeking a piece of Moderna's Covid riches, sue for patent infringement

4 years ago

FDA rejects Reata's kidney drug after adcomm voted unanimously against it

4 years ago

In latest setback for solid tumor CAR-T, Celyad pauses trial following two patient deaths

4 years ago

In all-encompassing rights deal with Huadong, Dietmar Hopp's Heidelberg looks to bring its ADCs to most of Asia

4 years ago

Biosimilars unite: Looking for commercial consolidation, Biocon buys out longtime partner Viatris for $3.3B

4 years ago

First page Previous page 575 576 577578579 580 581 Next page Last page